Jingyao M. Ma
No.56 Nanlishi Road
Beijing, 100045, China
Beijing, 100045, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications
Imidazolium Lipid-based Nanoparticles Enable Effective mRNA Delivery and Cellular Immune Response.
Journal: Materials today (Kidlington, England)
Published: June 01, 2026
Cell-nanoplastics association impacts cell proliferation and motility.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Engineering age-adaptive mRNA lipid nanoparticle cancer vaccines via reprogramming systemic gene expression.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Sea-blue histiocytosis and thrombocytopenia successfully treated with an mTORC1 inhibitor: a case report.
Journal: Annals of hematology
Published: April 10, 2026
Plasma metabolomics profile alterations in the onset and progression of paediatric immune thrombocytopenia.
Journal: British journal of haematology
Published: March 15, 2026
Overuse of thrombopoietin receptor agonists driven by suboptimal response is associated with myelofibrosis in pediatric immune thrombocytopenia.
Journal: Haematologica
Published: January 31, 2026
Buffer Valency Engineering Enables High-concentration and Shelf-stable DNA Transfection Particles for Viral Vector Production.
Journal: Research square
Published: November 24, 2025
Optimizing pediatric ITP therapy: a real-world study on plasma concentration-guided eltrombopag dosing.
Journal: Annals of hematology
Published: October 27, 2025
A multistep platform identifies spleen-tropic lipid nanoparticles for in vivo T cell-targeted delivery of gene-editing proteins.
Journal: Science advances
Published: October 22, 2025
Crosslinking of Lipid Nanoparticles Enhances the Delivery Efficiency and Efficacy of mRNA Vaccines.
Journal: bioRxiv : the preprint server for biology
Published: September 18, 2025
Last Updated: 09/26/2026